Moxisylyte (Compound)

Synonyms:Moxisylyte, Thymoxamine, 54-32-0, Acetoxythymoxamine, Carlytene, Moxilite, Moxisylyt, Arlytene, Opilon, Sympal, Vasoklin, Moxisylyte HCl, (2-(4-Acetoxy-2-isopropyl-5-methylphenoxy)ethyl)dimethylamine, 4-(2-(Dimethylamino)ethoxy)-5-isopropyl-2-methylphenyl acetate, PW8QYA7KI0, Timoxamina, Moxisylyte (INN), Thymoxamine hcl, MOXISYLYTE [INN], 6-Acetoxythymol 2-(dimethylamino)ethyl ether, Arlytene; Moxilite; Moxisylite; Moxisylyt; Moxisylyte, Moxisilita, Moxisylytum, [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate, Moxisylytum [INN-Latin], Moxisilita [INN-Spanish], NCGC00015678-02, CAS-964-52-3, EINECS 200-204-1, UNII-PW8QYA7KI0, Moxisylyte [INN:BAN:DCF], Carlytene (TN), Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester), Carvacrol, 5-(2-(dimethylamino)ethoxy)-, acetate (ester), MOXISYLYTE [MI], Prestwick0_000042, Prestwick1_000042, Prestwick2_000042, Prestwick3_000042, Lopac-M-5154, 4-(2-(Dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)phenol acetate (ester), MOXISYLYTE [WHO-DD], Lopac0_000767, 4-Dimethylaminoethoxycarvacrol, BSPBio_000163, SCHEMBL456546, SPBio_002084, BPBio1_000181, CHEMBL159226, DTXSID4023339, CHEBI:94754, GTPL12306, Pharmakon1600-01506079, BDBM50452139, NSC759308, ((6-Acetoxythymoxy)ethyl)dimethylamine, CCG-204852, DB09205, NSC-759308, SDCCGSBI-0050745.P003, NCGC00015678-01, NCGC00015678-03, NCGC00015678-04, NCGC00015678-05, NCGC00015678-06, NCGC00015678-07, NCGC00015678-08, NCGC00015678-13, NCGC00024362-03, SBI-0050745.P002, 5-(2-(Dimethylamino)ethoxy)carvacrol acetate, D08239, EN300-18567368, Q646045, SR-01000000205-7, BRD-K81144366-003-03-1, CARVACROL, 5-(2-(DIMETHYLAMINO)ETHOXY)-, ACETATE, [2-(4-Acetoxy-2-isopropyl-5-methylprhenoxy)ethyl]dimethylamine, 4-(2-Dimethylaminoethoxy)-2-methyl-5-isopropylphenyl acetate, 4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetate, 4-[2-(Dimethylamino)ethoxy]-2-methyl-5-(methylethyl)phenyl acetate, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(propan-2-yl)phenyl acetate, 4-{[2-(dimethylamino)ethyl]oxy}-2-methyl-5-(1-methylethyl)phenyl acetate, Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate, acetic acid [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] ester

Pubchem:PUBCHEM:4260

Id:18b2d431-2370-5fa1-86c0-222a4687bb44

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Moxisylyte's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Moxisylyte.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Moxisylyte.

Results found

Linked to

	Label	Description
	BRD-K81144366-003-19-7 Substance (Entity type)	A Substance
	moxisylyte (56165bdc-cd17-43b7-88e1-0f7bbabd65fc) Collection (Entity type)	Metadatata for moxisylyte
	DCSTRUCT ID 01855 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01855; PubChem_CID:4260, FILE=drugcentral_drug_01855.json)
	Moxisylyte negatively regulates STC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte positively regulates CDC20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte positively regulates RARRES2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte negatively regulates ATP8A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte in similarity relationship with Roflumilast Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte negatively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Moxisylyte negatively regulates PIP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS